172 related articles for article (PubMed ID: 3789250)
21. Cytologic features of pigmented atypical meningioma mimicking melanoma on intraoperative crush preparations.
Han SH; Joo M; Lee BH; Park SH
Diagn Cytopathol; 2015 Feb; 43(2):149-52. PubMed ID: 24692367
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
23. Is the Simpson Grading System Applicable to Estimate the Risk of Tumor Progression After Microsurgery for Recurrent Intracranial Meningioma?
Schipmann S; Schwake M; Sporns PB; Voß KM; Sicking J; Spille DC; Hess K; Paulus W; Stummer W; Brokinkel B
World Neurosurg; 2018 Nov; 119():e589-e597. PubMed ID: 30081236
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
25. Atypical and malignant meningiomas: a clinicopathological review.
Mahmood A; Caccamo DV; Tomecek FJ; Malik GM
Neurosurgery; 1993 Dec; 33(6):955-63. PubMed ID: 8134008
[TBL] [Abstract][Full Text] [Related]
26. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
27. Intracranial meningiomas: analysis of recurrence after surgical treatment.
Mahmood A; Qureshi NH; Malik GM
Acta Neurochir (Wien); 1994; 126(2-4):53-8. PubMed ID: 8042555
[TBL] [Abstract][Full Text] [Related]
28. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
29. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
[TBL] [Abstract][Full Text] [Related]
30. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
[TBL] [Abstract][Full Text] [Related]
31. Atypical (anaplastic) meningioma: relationship between histologic features and recurrence--a clinicopathologic study.
Chen WY; Liu HC
Clin Neuropathol; 1990; 9(2):74-81. PubMed ID: 2187642
[TBL] [Abstract][Full Text] [Related]
32. Spinal extradural en plaque meningiomas: clinical features and long-term outcomes of 12 cases.
Wu L; Yang T; Deng X; Yang C; Zhao L; Yao N; Fang J; Wang G; Yang J; Xu Y
J Neurosurg Spine; 2014 Dec; 21(6):892-8. PubMed ID: 25237843
[TBL] [Abstract][Full Text] [Related]
33. Anterior visual pathway meningiomas primarily resected between 1978 and 1988: the Mayo Clinic Rochester experience.
Stafford SL; Perry A; Leavitt JA; Garrity JA; Suman VJ; Scheithauer BW; Lohse CM; Meyer FB
J Neuroophthalmol; 1998 Sep; 18(3):206-10. PubMed ID: 9736208
[TBL] [Abstract][Full Text] [Related]
34. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
[TBL] [Abstract][Full Text] [Related]
35. Clinical, Radiologic, and Pathologic Features of 56 Cases of Intracranial Lymphoplasmacyte-Rich Meningioma.
Tao X; Wang K; Dong J; Hou Z; Wu Z; Zhang J; Liu B
World Neurosurg; 2017 Oct; 106():152-164. PubMed ID: 28673887
[TBL] [Abstract][Full Text] [Related]
36. Atypical Presentation of Transcranial Extension of Intracranial Meningiomas.
Nahm WJ; Gordhandas J; Hinds B
Am J Dermatopathol; 2022 Mar; 44(3):207-211. PubMed ID: 35171886
[TBL] [Abstract][Full Text] [Related]
37. Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent, and malignant tumors.
Salmon I; Kiss R; Levivier M; Remmelink M; Pasteels JL; Brotchi J; Flament-Durand J
Am J Surg Pathol; 1993 Mar; 17(3):239-47. PubMed ID: 8434704
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study on the recurrence of meningiomas: correlating factors for the recurrence and therapeutic prognosis of meningiomas].
Miyagami M; Miyagi A; Kido G; Tsubokawa T
No Shinkei Geka; 1994 May; 22(5):421-8. PubMed ID: 8196827
[TBL] [Abstract][Full Text] [Related]
39. Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen.
Pizem J; Velnar T; Prestor B; Mlakar J; Popovic M
Clin Neuropathol; 2014; 33(5):354-63. PubMed ID: 25034703
[TBL] [Abstract][Full Text] [Related]
40. Malignant meningioma: a clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry.
Prayson RA
Am J Clin Pathol; 1996 Jun; 105(6):719-26. PubMed ID: 8659446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
